Molecular Assessment of Staphylococcus Aureus Strains in STAT3 Hyper-IgE Syndrome Patients

[1]  C. Akdis,et al.  Impaired memory B‐cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper‐IgE syndrome , 2019, Allergy.

[2]  J. Rosenecker,et al.  Lung disease in STAT3 hyper‐IgE syndrome requires intense therapy , 2019, Allergy.

[3]  P. Gastmeier,et al.  Decrease of methicillin resistance in Staphylococcus aureus in nosocomial infections in Germany-a prospective analysis over 10 years. , 2019, The Journal of infection.

[4]  Alexandre Souvorov,et al.  SKESA: strategic k-mer extension for scrupulous assemblies , 2018, Genome Biology.

[5]  S. Holland,et al.  TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome , 2018, The Journal of clinical investigation.

[6]  R. Goering,et al.  Whole genome sequencing options for bacterial strain typing and epidemiologic analysis based on single nucleotide polymorphism versus gene-by-gene-based approaches. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  T. Eckmanns,et al.  Eigenschaften, Häufigkeit und Verbreitung von MRSA in Deutschland , 2018 .

[8]  D. Tabor,et al.  Characterisation of anti‐alpha toxin antibody levels and colonisation status after administration of an investigational human monoclonal antibody, MEDI4893, against Staphylococcus aureus alpha toxin , 2018, Clinical & translational immunology.

[9]  C. Weidenmaier,et al.  The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota , 2017, Nature Reviews Microbiology.

[10]  J. Parkhill,et al.  The Microevolution and Epidemiology of Staphylococcus aureus Colonization during Atopic Eczema Disease Flare , 2017, The Journal of investigative dermatology.

[11]  A. Mellmann,et al.  The Impact of the Staphylococcus aureus Virulome on Infection in a Developing Country: A Cohort Study , 2017, Front. Microbiol..

[12]  A. Freeman,et al.  Molecular Typing of Staphylococcus aureus Isolated from Patients with Autosomal Dominant Hyper IgE Syndrome , 2017, Pathogens.

[13]  B. Bröker,et al.  Reduced Immunoglobulin (Ig) G Response to Staphylococcus aureus in STAT3 Hyper-IgE Syndrome , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  G. Lina,et al.  IVIG-mediated protection against necrotizing pneumonia caused by MRSA , 2016, Science Translational Medicine.

[15]  A. Mellmann,et al.  Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting , 2016, Journal of Clinical Microbiology.

[16]  K. Schwarz,et al.  Key findings to expedite the diagnosis of hyper‐IgE syndromes in infants and young children , 2016, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[17]  P. Gastmeier,et al.  The reduction of nosocomial MRSA infection in Germany: an analysis of data from the Hospital Infection Surveillance System (KISS) between 2007 and 2012. , 2014, Deutsches Arzteblatt international.

[18]  Dag Harmsen,et al.  Bacterial Whole-Genome Sequencing Revisited: Portable, Scalable, and Standardized Analysis for Typing and Detection of Virulence and Antibiotic Resistance Genes , 2014, Journal of Clinical Microbiology.

[19]  R. Lynfield,et al.  Multistate point-prevalence survey of health care-associated infections. , 2014, The New England journal of medicine.

[20]  J. Suzich,et al.  Assessment of an Anti-Alpha-Toxin Monoclonal Antibody for Prevention and Treatment of Staphylococcus aureus-Induced Pneumonia , 2013, Antimicrobial Agents and Chemotherapy.

[21]  A. Fischer,et al.  Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome: Molecular, Cellular, and Clinical Features From a French National Survey , 2012, Medicine.

[22]  H. Ochs,et al.  Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation. , 2012, The Journal of allergy and clinical immunology.

[23]  H. Takada,et al.  Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome , 2009, The Journal of experimental medicine.

[24]  M. Leppert,et al.  Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. , 2008, Journal of Allergy and Clinical Immunology.

[25]  W. Paul,et al.  Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome , 2008, Nature.

[26]  Bodo Grimbacher,et al.  STAT3 mutations in the hyper-IgE syndrome. , 2007, The New England journal of medicine.

[27]  H. Ochs,et al.  STAT3 mutation in the original patient with Job's syndrome. , 2007, The New England journal of medicine.

[28]  H. Takada,et al.  Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome , 2007, Nature.

[29]  S. Holland,et al.  Causes of death in hyper-IgE syndrome. , 2007, The Journal of allergy and clinical immunology.

[30]  K. Omoe,et al.  Comprehensive analysis of classical and newly described staphylococcal superantigenic toxin genes in Staphylococcus aureus isolates. , 2005, FEMS microbiology letters.

[31]  S. Antonarakis,et al.  Nomenclature for the description of human sequence variations , 2001, Human Genetics.

[32]  A. Friedrich,et al.  Staphylococcus aureus from the German general population is highly diverse. , 2017, International journal of medical microbiology : IJMM.

[33]  H. Kimata.  High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome. , 1995, The Journal of allergy and clinical immunology.